About DELPHI STEM, LLC
Delphistem is developing a stem cell-based therapy to restore natural insulin production in people with diabetes. Their approach is non-invasive, cost-effective, and designed for scalability.
Stem cell-based therapy developmentCellular reprogrammingPancreatic islet developmentInsulin-producing cell differentiationBiotech platform development
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to DELPHI STEM, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.